Skip to Main Content
Menu
Close
About Us
Technology and Programs
mtDNA Upregulation
Publications and Presentations
Patients and Families
Join Us
News
Contact Us
Press Releases
Pretzel Therapeutics Launches With $72.5 Million Series A Financing to Pioneer Mitochondrial Therapies
September 12, 2022